{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:12:43Z","timestamp":1793167963798,"version":"4.5.0"},"reference-count":51,"publisher":"National Academy of Sciences","issue":"36","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2014,9,9]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>\n                    The human gut microbiota is a complex community of microbes with enormous metabolic potential. Recognition of the significance of bacterial metabolites in mediating host interactions and the impact of perturbations of this ecosystem on human health has increased dramatically. Antibiotic therapy eliminates not only pathogens but also some of the commensal enteric microbiota, sometimes leading to inflammation and diarrhea. Understanding how microbial imbalance actually causes disease is challenging. This study reveals how a gut resident is able to cause colitis during penicillin therapy. We show that a pyrrolobenzodiazepine metabolite produced by\n                    <jats:italic>Klebsiella oxytoca<\/jats:italic>\n                    directly damages the intestinal epithelium and disrupts its protective barrier function. The enterotoxicity of tilivalline provides a mechanism for antibiotic-induced colitis.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1403274111","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T23:20:35Z","timestamp":1409008835000},"page":"13181-13186","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":129,"title":["Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis"],"prefix":"10.1073","volume":"111","author":[{"given":"Georg","family":"Schneditz","sequence":"first","affiliation":[{"name":"Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Rentner","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Roier","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Pletz","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin A. T.","family":"Herzog","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"B\u00fccker","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Infectiology and Rheumatology, Charit\u00e9 \u2013 Campus Benjamin Franklin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Troeger","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Infectiology and Rheumatology, Charit\u00e9 \u2013 Campus Benjamin Franklin, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schild","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Breinbauer","sequence":"additional","affiliation":[{"name":"Institute of Organic Chemistry, Graz University of Technology, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Gorkiewicz","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University of Graz, 8036 Graz, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"H\u00f6genauer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Zechner","sequence":"additional","affiliation":[{"name":"Institute of Molecular Biosciences, University of Graz, 8010 Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2014,8,25]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg PB","year":"2005","unstructured":"PB Eckburg, et al., Diversity of the human intestinal microbial flora. Science 308, 1635\u20131638 (2005).","journal-title":"Science"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","article-title":"The gut microbiota\u2014masters of host development and physiology","volume":"11","author":"Sommer F","year":"2013","unstructured":"F Sommer, F B\u00e4ckhed, The gut microbiota\u2014masters of host development and physiology. Nat Rev Microbiol 11, 227\u2013238 (2013).","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson FH","year":"2013","unstructured":"FH Karlsson, et al., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99\u2013103 (2013).","journal-title":"Nature"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto S","year":"2013","unstructured":"S Yoshimoto, et al., Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97\u2013101 (2013).","journal-title":"Nature"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1219328","article-title":"Microbial exposure during early life has persistent effects on natural killer T cell function","volume":"336","author":"Olszak T","year":"2012","unstructured":"T Olszak, et al., Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489\u2013493 (2012).","journal-title":"Science"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl B","year":"2014","unstructured":"B Schnabl, DA Brenner, Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513\u20131524 (2014).","journal-title":"Gastroenterology"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia J","year":"2012","unstructured":"J Henao-Mejia, et al., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179\u2013185 (2012).","journal-title":"Nature"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mib.2013.07.002","article-title":"Colonic bacterial metabolites and human health","volume":"16","author":"Russell WR","year":"2013","unstructured":"WR Russell, L Hoyles, HJ Flint, ME Dumas, Colonic bacterial metabolites and human health. Curr Opin Microbiol 16, 246\u2013254 (2013).","journal-title":"Curr Opin Microbiol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/514958","article-title":"Mechanisms and management of antibiotic-associated diarrhea","volume":"27","author":"H\u00f6genauer C","year":"1998","unstructured":"C H\u00f6genauer, HF Hammer, GJ Krejs, EC Reisinger, Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27, 702\u2013710 (1998).","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrmicro2989","article-title":"\u2018Blooming\u2019 in the gut: How dysbiosis might contribute to pathogen evolution","volume":"11","author":"Stecher B","year":"2013","unstructured":"B Stecher, L Maier, WD Hardt, \u2018Blooming\u2019 in the gut: How dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 11, 277\u2013284 (2013).","journal-title":"Nat Rev Microbiol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nm.2729","article-title":"Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota","volume":"18","author":"Ayres JS","year":"2012","unstructured":"JS Ayres, NJ Trinidad, RE Vance, Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 18, 799\u2013806 (2012).","journal-title":"Nat Med"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round JL","year":"2009","unstructured":"JL Round, SK Mazmanian, The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9, 313\u2013323 (2009).","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1053\/S1542-3565(03)00183-6","article-title":"Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis","volume":"1","author":"Beaugerie L","year":"2003","unstructured":"L Beaugerie, et al., Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol; Infectious Colitis Study Group 1, 370\u2013376 (2003).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa054765","article-title":"Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis","volume":"355","author":"H\u00f6genauer C","year":"2006","unstructured":"C H\u00f6genauer, et al., Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 355, 2418\u20132426 (2006).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1086\/592074","article-title":"Role of Klebsiella oxytoca in antibiotic-associated diarrhea","volume":"47","author":"Zollner-Schwetz I","year":"2008","unstructured":"I Zollner-Schwetz, et al., Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis 47, e74\u2013e78 (2008).","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"beta-Lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore DM","year":"1995","unstructured":"DM Livermore, beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8, 557\u2013584 (1995).","journal-title":"Clin Microbiol Rev"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.coi.2011.07.010","article-title":"Pathobionts of the gastrointestinal microbiota and inflammatory disease","volume":"23","author":"Chow J","year":"2011","unstructured":"J Chow, H Tang, SK Mazmanian, Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr Opin Immunol 23, 473\u2013480 (2011).","journal-title":"Curr Opin Immunol"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0882-4010(89)90056-9","article-title":"Production of a unique cytotoxin by Klebsiella oxytoca","volume":"7","author":"Minami J","year":"1989","unstructured":"J Minami, A Okabe, J Shiode, H Hayashi, Production of a unique cytotoxin by Klebsiella oxytoca. Microb Pathog 7, 203\u2013211 (1989).","journal-title":"Microb Pathog"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/JCM.01741-09","article-title":"Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects","volume":"48","author":"Joainig MM","year":"2010","unstructured":"MM Joainig, et al., Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects. J Clin Microbiol 48, 817\u2013824 (2010).","journal-title":"J Clin Microbiol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1348-0421.1990.tb00999.x","article-title":"Cytotoxic component(s) of Klebsiella oxytoca on Hep-2 cells","volume":"34","author":"Higaki M","year":"1990","unstructured":"M Higaki, T Chida, H Takano, R Nakaya, Cytotoxic component(s) of Klebsiella oxytoca on Hep-2 cells. Microbiol Immunol 34, 147\u2013151 (1990).","journal-title":"Microbiol Immunol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/JCM.03373-13","article-title":"Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis","volume":"52","author":"Herzog KA","year":"2014","unstructured":"KA Herzog, et al., Genotypes of Klebsiella oxytoca isolates from patients with nosocomial pneumonia are distinct from those of isolates from patients with antibiotic-associated hemorrhagic colitis. J Clin Microbiol 52, 1607\u20131616 (2014).","journal-title":"J Clin Microbiol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/psc.1183","article-title":"Working outside the protein-synthesis rules: Insights into non-ribosomal peptide synthesis","volume":"15","author":"Marahiel MA","year":"2009","unstructured":"MA Marahiel, Working outside the protein-synthesis rules: Insights into non-ribosomal peptide synthesis. J Pept Sci 15, 799\u2013807 (2009).","journal-title":"J Pept Sci"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1021\/cr0503097","article-title":"Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: Logic, machinery, and mechanisms","volume":"106","author":"Fischbach MA","year":"2006","unstructured":"MA Fischbach, CT Walsh, Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: Logic, machinery, and mechanisms. Chem Rev 106, 3468\u20133496 (2006).","journal-title":"Chem Rev"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(09)04808-3","article-title":"Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data","volume":"458","author":"Bachmann BO","year":"2009","unstructured":"BO Bachmann, J Ravel, Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data. Methods Enzymol 458, 181\u2013217 (2009).","journal-title":"Methods Enzymol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1074-5521(99)80082-9","article-title":"The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases","volume":"6","author":"Stachelhaus T","year":"1999","unstructured":"T Stachelhaus, HD Mootz, MA Marahiel, The specificity-conferring code of adenylation domains in nonribosomal peptide synthetases. Chem Biol 6, 493\u2013505 (1999).","journal-title":"Chem Biol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/S0021-9258(18)48643-7","article-title":"The enzymic conversion of 3-deoxy-D-arabino-heptulosonic acid 7-phosphate to 5-dehydroquinate","volume":"238","author":"Srinivasan PR","year":"1963","unstructured":"PR Srinivasan, J Rothschild, DB Sprinson, The enzymic conversion of 3-deoxy-D-arabino-heptulosonic acid 7-phosphate to 5-dehydroquinate. J Biol Chem 238, 3176\u20133182 (1963).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.arplant.50.1.473","article-title":"The shikimate pathway","volume":"50","author":"Herrmann KM","year":"1999","unstructured":"KM Herrmann, LM Weaver, The shikimate pathway. Annu Rev Plant Physiol Plant Mol Biol 50, 473\u2013503 (1999).","journal-title":"Annu Rev Plant Physiol Plant Mol Biol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1104\/pp.107.1.7","article-title":"The shikimate pathway as an entry to aromatic secondary metabolism","volume":"107","author":"Herrmann KM","year":"1995","unstructured":"KM Herrmann, The shikimate pathway as an entry to aromatic secondary metabolism. Plant Physiol 107, 7\u201312 (1995).","journal-title":"Plant Physiol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2958.1998.01124.x","article-title":"The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes","volume":"30","author":"Buchrieser C","year":"1998","unstructured":"C Buchrieser, R Brosch, S Bach, A Guiyoule, E Carniel, The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes. Mol Microbiol 30, 965\u2013978 (1998).","journal-title":"Mol Microbiol"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JB.01219-07","article-title":"Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess","volume":"190","author":"Lin TL","year":"2008","unstructured":"TL Lin, CZ Lee, PF Hsieh, SF Tsai, JT Wang, Characterization of integrative and conjugative element ICEKp1-associated genomic heterogeneity in a Klebsiella pneumoniae strain isolated from a primary liver abscess. J Bacteriol 190, 515\u2013526 (2008).","journal-title":"J Bacteriol"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1365-2958.2003.03870.x","article-title":"A novel integrative and conjugative element (ICE) of Escherichia coli: The putative progenitor of the Yersinia high-pathogenicity island","volume":"51","author":"Schubert S","year":"2004","unstructured":"S Schubert, S Dufke, J Sorsa, J Heesemann, A novel integrative and conjugative element (ICE) of Escherichia coli: The putative progenitor of the Yersinia high-pathogenicity island. Mol Microbiol 51, 837\u2013848 (2004).","journal-title":"Mol Microbiol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1128\/IAI.00522-09","article-title":"Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae","volume":"77","author":"Putze J","year":"2009","unstructured":"J Putze, et al., Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 77, 4696\u20134703 (2009).","journal-title":"Infect Immun"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1128\/AEM.02325-08","article-title":"Cloning and characterization of the biosynthetic gene cluster for tomaymycin, an SJG-136 monomeric analog","volume":"75","author":"Li W","year":"2009","unstructured":"W Li, S Chou, A Khullar, B Gerratana, Cloning and characterization of the biosynthetic gene cluster for tomaymycin, an SJG-136 monomeric analog. Appl Environ Microbiol 75, 2958\u20132963 (2009).","journal-title":"Appl Environ Microbiol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/AEM.02326-08","article-title":"Biosynthesis of sibiromycin, a potent antitumor antibiotic","volume":"75","author":"Li W","year":"2009","unstructured":"W Li, A Khullar, S Chou, A Sacramo, B Gerratana, Biosynthesis of sibiromycin, a potent antitumor antibiotic. Appl Environ Microbiol 75, 2869\u20132878 (2009).","journal-title":"Appl Environ Microbiol"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chembiol.2007.05.009","article-title":"Benzodiazepine biosynthesis in Streptomyces refuineus","volume":"14","author":"Hu Y","year":"2007","unstructured":"Y Hu, et al., Benzodiazepine biosynthesis in Streptomyces refuineus. Chem Biol 14, 691\u2013701 (2007).","journal-title":"Chem Biol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1021\/bi00586a029","article-title":"Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic sibiromycin by Streptosporangium sibiricum","volume":"18","author":"Hurley LH","year":"1979","unstructured":"LH Hurley, WL Lasswell, RK Malhotra, NV Das, Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic sibiromycin by Streptosporangium sibiricum. Biochemistry 18, 4225\u20134229 (1979).","journal-title":"Biochemistry"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0040-4020(82)85058-8","article-title":"Tilivalline, a new pyrrolo[2, 1-c][1,4] benzodiazepine metabolite from klebsiella","volume":"38","author":"Mohr N","year":"1982","unstructured":"N Mohr, H Budzikiewicz, Tilivalline, a new pyrrolo[2, 1-c][1,4] benzodiazepine metabolite from klebsiella. Tetrahedron 38, 147\u2013152 (1982).","journal-title":"Tetrahedron"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1021\/jo972158g","article-title":"Stereoselective synthesis of tilivalline(1)","volume":"63","author":"Nagasaka T","year":"1998","unstructured":"T Nagasaka, Y Koseki, Stereoselective synthesis of tilivalline(1). J Org Chem 63, 6797\u20136801 (1998).","journal-title":"J Org Chem"},{"key":"e_1_3_4_39_2","first-page":"167","article-title":"Structure-cytotoxicity relationship of tilivalline derivatives","volume":"10","author":"Shioiri T","year":"1995","unstructured":"T Shioiri, et al., Structure-cytotoxicity relationship of tilivalline derivatives. Anticancer Drug Des 10, 167\u2013176 (1995).","journal-title":"Anticancer Drug Des"},{"key":"e_1_3_4_40_2","first-page":"293","volume-title":"Emerging Infections","author":"H\u00f6genauer C","year":"2008","unstructured":"C H\u00f6genauer, T Hinterleitner, Klebsiella oxytoca as a cause of antibiotic-associated colitis. Emerging Infections, eds WMHS Scheld, JM Hughes (ASM, Washington, DC), pp. 293\u2013311 (2008)."},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1127059","article-title":"Escherichia coli induces DNA double-strand breaks in eukaryotic cells","volume":"313","author":"Nougayr\u00e8de JP","year":"2006","unstructured":"JP Nougayr\u00e8de, et al., Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848\u2013851 (2006).","journal-title":"Science"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"e96292","DOI":"10.1371\/journal.pone.0096292","article-title":"Genotoxic Klebsiella pneumoniae in Taiwan","volume":"9","author":"Lai YC","year":"2014","unstructured":"YC Lai, et al., Genotoxic Klebsiella pneumoniae in Taiwan. PloS ONE 9, e96292 (2014).","journal-title":"PloS ONE"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/med.20212","article-title":"Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines","volume":"32","author":"Gerratana B","year":"2012","unstructured":"B Gerratana, Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines. Med Res Rev 32, 254\u2013293 (2012).","journal-title":"Med Res Rev"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/np980495u","article-title":"Circumdatins D, E, and F: Further fungal benzodiazepine analogues from aspergillus ochraceus","volume":"62","author":"Rahbaek L","year":"1999","unstructured":"L Rahbaek, J Breinholt, Circumdatins D, E, and F: Further fungal benzodiazepine analogues from aspergillus ochraceus. J Nat Prod 62, 904\u2013905 (1999).","journal-title":"J Nat Prod"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ja.2005.54","article-title":"Circumdatin H, a new inhibitor of mitochondrial NADH oxidase, from Aspergillus ochraceus","volume":"58","author":"L\u00f3pez-Gresa MP","year":"2005","unstructured":"MP L\u00f3pez-Gresa, et al., Circumdatin H, a new inhibitor of mitochondrial NADH oxidase, from Aspergillus ochraceus. J Antibiot (Tokyo) 58, 416\u2013419 (2005).","journal-title":"J Antibiot (Tokyo)"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur JC","year":"2012","unstructured":"JC Arthur, et al., Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120\u2013123 (2012).","journal-title":"Science"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.1001261107","article-title":"Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells","volume":"107","author":"Cuevas-Ramos G","year":"2010","unstructured":"G Cuevas-Ramos, et al., Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA 107, 11537\u201311542 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"e77157","DOI":"10.1371\/journal.pone.0077157","article-title":"Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells","volume":"8","author":"Secher T","year":"2013","unstructured":"T Secher, A Samba-Louaka, E Oswald, JP Nougayr\u00e8de, Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PloS ONE 8, e77157 (2013).","journal-title":"PloS ONE"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0005-2787(77)90067-3","article-title":"Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules","volume":"475","author":"Hurley LH","year":"1977","unstructured":"LH Hurley, C Gairola, M Zmijewski, Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules. Biochim Biophys Acta 475, 521\u2013535 (1977).","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1517\/13543784.2011.573477","article-title":"The development of pyrrolobenzodiazepines as antitumour agents","volume":"20","author":"Hartley JA","year":"2011","unstructured":"JA Hartley, The development of pyrrolobenzodiazepines as antitumour agents. Expert Opin Investig Drugs 20, 733\u2013744 (2011).","journal-title":"Expert Opin Investig Drugs"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7164\/antibiotics.30.349","article-title":"Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin","volume":"30","author":"Hurley LH","year":"1977","unstructured":"LH Hurley, Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot (Tokyo) 30, 349\u2013370 (1977).","journal-title":"J Antibiot (Tokyo)"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1403274111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T07:23:57Z","timestamp":1654586637000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1403274111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,25]]},"references-count":51,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2014,9,9]]}},"alternative-id":["10.1073\/pnas.1403274111"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1403274111","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718544525.793513849","asserted-by":"object"}]},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,25]]},"assertion":[{"value":"2014-08-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}